logo

For the Inventor, By the Inventor

Hong Kong, China

Jun Yu

This inventor holds 20 USPTO granted patents and 3 published patent applications and 1 EPO patent, primarily in Colorectal Cancer Research. Top assignee: The Chinese University of Hong Kong. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Yu. Retrieved from https://idiyas.com/inventor/jun-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 85.0

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Shatin N. T., CN (2019)
  • Shatin, CN (2019)
  • Lake Silver, CN (2014 - 2020)
  • Hong Kong, CN (2014 - 2023)
  • Ma On Shan, CN (2024)

Company Filing History:

goldMedal20 out of 504 
 
The Chinese University of Hong Kong
 patents

Years Active: 2014-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Probiotics
Colorectal Cancer
Biomarkers
Tumor Suppressors
Squalene Epoxidase
Gastric Cancer
Epigenetic Biomarkers
Fecal Bacterial Markers
Chemoprevention
Diagnosis
Non-Alcoholic Fatty Liver Disease
20 patents (USPTO):Explore Patents
1. 12636325 - Probiotic compositions for treating and preventing colorectal cancer (2026-05-26),
2. 12478649 - Therapeutic and prophylactic treatment for colorectal cancer (2025-11-25),
3. 12275995 - and aspirin chemoprevention of colorectal cancer (2025-04-14),
4. 11975034 - Probiotic compositions for treating and preventing colorectal cancer (2024-05-07),
5. 11603567 - Fecal bacterial markers for colorectal cancer (2023-03-14),
6. 11554145 - Therapeutic and prophylactic treatment for colorectal cancer (2023-01-17),
7. 11340226 - Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases (2022-05-24),
8. 11111547 - Tumor suppressor REC8 as a biomarker for gastric cancer (2021-09-07),
9. 10900091 - miR-133a as a marker for colorectal cancer (2021-01-26),
10. 10724101 - Biomarker SCNN1B for gastric cancer (2020-07-28),
11. 10457993 - Biomarker RNF6 for colorectal cancer (2019-10-29),
12. 10379124 - Tumor suppressor VSTM2A as a biomarker for colorectal cancer (2019-08-13),
13. 10364471 - Tumor suppressor REC8 as a biomarker for gastric cancer (2019-07-30),
14. 10294530 - Biomarker FOXF2 for gastric cancer (2019-05-21),
15. 9394570 - Marker for colon cancer and method for detecting colon cancer (2016-07-19),

Title: Inventor Jun Yu - Revolutionizing Technology in Hong Kong

Introduction: Jun Yu is a visionary inventor hailing from the bustling city of Hong Kong, China. With a passion for innovation and a keen eye for technological advancements, he has made significant contributions to the field of technology.

Latest Patents: Jun Yu holds several groundbreaking patents in the areas of artificial intelligence, renewable energy, and biotechnology. His recent patents focus on sustainable solutions for a greener future and cutting-edge advancements in AI technology.

Career Highlights: Throughout his illustrious career, Jun Yu has worked with top research institutions and leading tech companies to bring his inventions to life. His dedication to pushing the boundaries of technology has earned him recognition as a pioneer in his field.

Collaborations: Jun Yu has collaborated with renowned scientists, engineers, and researchers on various projects, fostering a culture of innovation and knowledge-sharing. His collaborative efforts have led to the development of cutting-edge technologies that have the potential to shape the future.

Conclusion: In conclusion, Jun Yu's innovative spirit and relentless pursuit of technological advancement have solidified his position as a prominent figure in the world of inventors. His contributions to the field continue to inspire and pave the way for future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…